Insider trades
Ross Muken, President of SOPHiA Genetics SOPH, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $114.9K. The latest trade was on 06/22.
Ross Muken
President
- Company
- SOPHiA Genetics SOPH
- First filing
- 25/03/19
- Trades
- 15 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$114.9K
- Last trade
- 06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/22 | 06/23 | 422 sh | $5.38 | $2,270.36 | −0.1% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/19 | 05/20 | 761 sh | $4.60 | $3,500.6 | −0.1% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 04/20 | 04/21 | 760 sh | $5.20 | $3,952 | −0.1% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 04/14 | 04/16 | 2,800 sh | $4.96 | $13,888 | −0.4% |
| Open-market sale10b5-1 plan | 04/10–04/13 | 04/14 | 8,129 sh2 trades | $4.73avg. | $38,480.37 | −1.2% | |
| Open-market sale10b5-1 plan | 04/08–04/09 | 04/10 | 4,736 sh2 trades | $4.80avg. | $22,727.24 | −0.7% | |
| Open-market sale10b5-1 plan | 04/06–04/07 | 04/08 | 5,024 sh2 trades | $4.86avg. | $24,414.88 | −0.7% | |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 03/19 | 03/20 | 1,183 sh | $4.79 | $5,666.57 | −0.4% |